Theriva Biologics (TOVX) Non-Current Assets (2010 - 2026)
Theriva Biologics (TOVX) posted Non-Current Assets of $21.19 million for Q2 2026, up 0.5% from $21.09 million a year earlier but down 1.4% from the prior quarter.
Powered by 
Analysis
Theriva Biologics (TOVX) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Theriva Biologics' Non-Current Assets came in at $20.77 million, up 8.9% from FY2024.
- Annual Non-Current Assets shows a five-year compound annual growth rate of 112.8% (FY2020 to FY2025).
- In prior years, Theriva Biologics' Non-Current Assets was $19.07 million in FY2024 (-31.4%), $27.82 million in FY2023 (+5.6%), $26.34 million in FY2022 and $1.51 million in FY2021 (+216.6%).
- Quarterly Non-Current Assets has run from a low of $1.51 million in Q4 2021 to a high of $29.44 million in Q1 2022 over five years.
- On a year-over-year basis, Non-Current Assets has increased in each of the last four quarters, with an average decline of 8.6% over the last eight quarters.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was Q4 2021, with growth of 216.6%; the weakest was Q4 2024, with a decline of 31.4%.
- According to Business Quant data, Non-Current Assets for the three prior quarters was $21.49 million (Q1 2026), $20.77 million (Q4 2025) and $20.93 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Theriva Biologics | 9.11 Mn | -37.25 Mn | - | 21.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.19 Mn |
| Mar 31, 2026 | 21.49 Mn |
| Dec 31, 2025 | 20.77 Mn |
| Sep 30, 2025 | 20.93 Mn |
| Jun 30, 2025 | 21.09 Mn |
| Mar 31, 2025 | 19.69 Mn |
| Dec 31, 2024 | 19.07 Mn |
| Sep 30, 2024 | 20.58 Mn |
| Jun 30, 2024 | 22.68 Mn |
| Mar 31, 2024 | 27.07 Mn |
| Dec 31, 2023 | 27.82 Mn |
| Sep 30, 2023 | 26.78 Mn |
| Jun 30, 2023 | 27.48 Mn |
| Mar 31, 2023 | 27.59 Mn |
| Dec 31, 2022 | 26.34 Mn |
| Sep 30, 2022 | 24.38 Mn |
| Jun 30, 2022 | 25.75 Mn |
| Mar 31, 2022 | 29.44 Mn |
| Dec 31, 2021 | 1.51 Mn |
| Sep 30, 2021 | 1.56 Mn |
API Access
Theriva Biologics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=TOVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "TOVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=TOVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();